In order to test whether NBAT1 regulates EZH2 functions, we then applied EZH2 inhibitors EI1 or GSK343 in MDA-MB-231 breast cancer cells with NBAT1 over-expression. The gene discussed is NBAT1; the disease is breast carcinoma.